https://www.selleckchem.com/pr....oducts/gsk650394.htm
56 months (95% confidence interval [CI] 6.23-8.88), and median OS was 12.16 months (95% CI 10.08-14.24). Common chemotherapy-related grade 3/4 side effects included vomiting in 25 patients (17.9%), diarrhea in 23 patients (16.4%), and thrombocytopenia in 22 patients (15.7%). Conclusion The current study in advanced CCAs is the largest of its nature from India. The common regimens used as first line were GC and GO. Tolerance and overall survival appear similar to previously published data. By using integrative RNA sequencing analysis,
Like
Comment
Share
